HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
Fig 1
In-silico modeling of the molecular interaction between HLA-A*1101 and LEV.
The LEV molecule was predicted to be docked into the P1 pocket of HLA-A*1101 with relatively higher affinity (5.1 kcal/mol) compared to other HLA-A subtypes. HLA, human leukocyte antigen; LEV, levetiracetam.